Boehringer Ingelheim Vetmedica, Inc.
Pet Division
3902 Gene Field Road
St. Joseph, Missouri 64506
- Phone 866-638-2226
- Fax 816-326-9167
Value Through Innovation19 June 2013
Vetmedin®
(pimobendan)
VETMEDIN (pimobendan) chewable tablet is a versatile, first-line therapy for the treatment of congestive heart failure due to atrioventricular insufficiency or dilated cardiomyopathy. VETMEDIN is recommended for use at the onset of clinical signs of CHF. Don’t Wait to add VETMEDIN to your standard protocol for CHF.
Key Selling Points
- Studies have shown VETMEDIN may extend and improve life for dogs with CHF due to AVVI and DCM. 3,4
- As the only FDA approved veterinary inodilator, VETMEDIN is both a positive inotrope and a balanced vasodilator.
- Easy to administer chewable tablets
- Works quickly and reliably when clinical signs of Congestive Heart Failure are present
- Labeled for both AVVI and DCM1,2
VETMEDIN should not be given in case of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. The safety of VETMEDIN has not been established in dogs with asymptomatic heart disease or in heart failure caused by etiologies other than atrioventricular valvular insufficiency or dilated cardiomyopathy. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure. The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. If side effects should occur, pet owners should contact their veterinarian. Please refer to the Full Prescribing Information here.
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian
Features
- As the only FDA approved veterinary inodilator, VETMEDIN is both a positive inotrope and a balanced vasodilator.
- Works effectively and safely2
- Well tolerated1
- Easy to administer1
- Palatable1
Benefits
- Studies have shown VETMEDIN may extend and improve life for dogs with CHF due to AVVI and DCM. 3,4
- Easy to administer chewable tablets
- Works quickly and reliably when clinical signs of Congestive Heart Failure are present
- 1.25 mg tablets
- 5.0 mg tablets
Administer orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight, using a suitable combination of whole or half tablets. The total daily dose should be divided into two portions that are not necessarily equal, and the portions should be administered approximately 12 hours apart (i.e., morning and evening). The tablets are scored and the calculated dosage should be provided to the nearest half tablet increment.1
References
1. Vetmedin® (pimobendan) Chewable Tablets [Package Insert]. St. Joseph, MO. Boehringer Ingelheim Vetmedica Inc. 2007.
2. Vetmedin® (pimobendan) Chewable Tablets [Freedom of Information Summary]. St. Joseph, MO. Boehringer Ingelheim Vetmedica Inc. 2007.
3. Häggström J et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: The QUEST study. J Vet Med. 2008;22:1124-1135.
4. Lombard CW, Jöns O, Bussadori CM; for the VetSCOPE Study. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249–261.
